NO994900D0 - Forbindelser - Google Patents

Forbindelser

Info

Publication number: NO994900D0
Authority: NO; Norway
Prior art keywords: compounds
Prior art date: 1997-04-09

Application number

NO994900A

Other languages

English (en)

Other versions

NO994900L (no

Inventor

Thomas Mcinally

Alan Tinker

Original Assignee

Astra Pharma Prod

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-04-09

Filing date

1999-10-08

Publication date

1999-10-08

1999-10-08 Application filed by Astra Pharma Prod filed Critical Astra Pharma Prod

1999-10-08 Publication of NO994900D0 publication Critical patent/NO994900D0/no

1999-11-19 Publication of NO994900L publication Critical patent/NO994900L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pulmonology (AREA)
Pain & Pain Management (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

NO994900A 1997-04-09 1999-10-08 Forbindelser NO994900L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE9701304A SE9701304D0 (sv)	1997-04-09	1997-04-09	Compounds
PCT/SE1998/000641 WO1998045294A1 (en)	1997-04-09	1998-04-07	Compounds

Publications (2)

Publication Number	Publication Date
NO994900D0 true NO994900D0 (no)	1999-10-08
NO994900L NO994900L (no)	1999-11-19

Family

ID=20406499

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO994900A NO994900L (no)	1997-04-09	1999-10-08	Forbindelser

Country Status (21)

Country	Link
US (1)	US6303613B1 (no)
EP (1)	EP0973772A1 (no)
JP (1)	JP2001519805A (no)
KR (1)	KR20010006143A (no)
CN (1)	CN1259131A (no)
AU (1)	AU7091098A (no)
BR (1)	BR9807950A (no)
CA (1)	CA2285388A1 (no)
CZ (1)	CZ355199A3 (no)
EE (1)	EE9900448A (no)
HU (1)	HUP0001865A2 (no)
ID (1)	ID23861A (no)
IL (1)	IL132085A0 (no)
IS (1)	IS5208A (no)
NO (1)	NO994900L (no)
NZ (1)	NZ338006A (no)
PL (1)	PL336141A1 (no)
SE (1)	SE9701304D0 (no)
SK (1)	SK128999A3 (no)
TR (1)	TR199902495T2 (no)
WO (1)	WO1998045294A1 (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6858598B1 (en)	1998-12-23	2005-02-22	G. D. Searle & Co.	Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US6833373B1 (en)	1998-12-23	2004-12-21	G.D. Searle & Co.	Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
SE9901530D0 (sv) *	1999-04-28	1999-04-28	Astra Pharma Prod	Novel compounds
US7172769B2 (en)	1999-12-08	2007-02-06	Pharmacia Corporation	Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
US20020077328A1 (en) *	2000-07-13	2002-06-20	Fred Hassan	Selective cyclooxygenase-2 inhibitors and vasomodulator compounds for generalized pain and headache pain
NZ524252A (en)	2000-07-20	2004-03-26	Lauras As	Cox-2 inhibitors for treating HIV and AIDS
GB0216027D0 (en) *	2002-07-10	2002-08-21	Arachnova Therapeutics Ltd	New therapeutic use
US20040048874A1 (en) *	2001-05-22	2004-03-11	Bardsley Hazel Judith	New therapeutic use of 4-(2-fluorophenyl)-6-methyl-2-(1-piperazinyl)thieno[2,3-D]pyrimidine
AR038957A1 (es)	2001-08-15	2005-02-02	Pharmacia Corp	Terapia de combinacion para el tratamiento del cancer
CA2482510A1 (en) *	2002-04-18	2003-10-30	Pharmacia Corporation	Monotherapy for the treatment of parkinson`s disease with cyclooxygenase-2 (cox 2) inhibitor(s)
EP1494664A2 (en) *	2002-04-18	2005-01-12	Pharmacia Corporation	Combinations of cox-2 inhibitors and other agents for the treatment of parkinson's disease
AU2003260033A1 (en) *	2002-08-29	2004-03-19	Schering Aktiengesellschaft	Methods of treating acute respiratory distress syndrome
AU2004204825B2 (en) *	2003-01-13	2007-07-19	Dynogen Pharmaceuticals, Inc.	Method of treating functional bowel disorders
KR100594377B1 (ko) *	2003-05-17	2006-06-30	한국생명공학연구원	항염증 활성을 갖는 신규 2-옥소-피페리딘 유도체(ⅰ)화합물, 이의 제조방법 및 이를 포함하는 염증 질환의치료를 위한 조성물
EP1626961B1 (en) *	2003-05-17	2011-11-02	Korea Research Institute of Bioscience and Biotechnology	Novel 2-oxo-heterocyclic compounds and the pharmaceutical compositions comprising the same
DE102005024012A1 (de) *	2005-05-20	2006-11-23	Grünenthal GmbH	Verwendung von 2,5-disubstituierten Thiazol-4-on-Derivaten in Arzneimitteln
TW200738658A (en)	2005-08-09	2007-10-16	Astrazeneca Ab	Novel compounds
PL1924264T3 (pl) *	2005-09-01	2014-03-31	Hoffmann La Roche	Diaminopirymidyny jako modulatory P2X<sub>3</sub> I P2X<sub>2/3</sub>
TW200745067A (en)	2006-03-14	2007-12-16	Astrazeneca Ab	Novel compounds
TW200833670A (en)	2006-12-20	2008-08-16	Astrazeneca Ab	Novel compounds 569
GB0702458D0 (en)	2007-02-08	2007-03-21	Astrazeneca Ab	Salts 668
KR20110017456A (ko)	2008-06-18	2011-02-21	아스트라제네카 아베	호흡기 장애의 치료를 위한 베타2-아드레날린성 수용체 효능제로서 작용하는 벤족사지논 유도체
US20240165148A1 (en)	2021-03-15	2024-05-23	Saul Yedgar	Hyaluronic acid-conjugated dipalmitoyl phosphatidyl ethanolamine in combination with non-steroidal anti-inflammatory drugs (nsaids) for treating or alleviating inflammatory diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3403152A (en) *	1967-03-20	1968-09-24	Ciba Geigy Corp	1-aryl-4-imino-1, 2, 3, 4-tetrahydroquinazolines
US3483205A (en) *	1967-12-22	1969-12-09	Ciba Geigy Corp	Bicyclic tetrahydropyrimidines
SE9703693D0 (sv) *	1997-10-10	1997-10-10	Astra Pharma Prod	Novel combination

1997
- 1997-04-09 SE SE9701304A patent/SE9701304D0/xx unknown
1998
- 1998-04-07 AU AU70910/98A patent/AU7091098A/en not_active Abandoned
- 1998-04-07 IL IL13208598A patent/IL132085A0/xx unknown
- 1998-04-07 TR TR1999/02495T patent/TR199902495T2/xx unknown
- 1998-04-07 JP JP54270198A patent/JP2001519805A/ja active Pending
- 1998-04-07 CA CA002285388A patent/CA2285388A1/en not_active Abandoned
- 1998-04-07 ID IDW991160A patent/ID23861A/id unknown
- 1998-04-07 PL PL98336141A patent/PL336141A1/xx unknown
- 1998-04-07 BR BR9807950-6A patent/BR9807950A/pt not_active IP Right Cessation
- 1998-04-07 CN CN98805845A patent/CN1259131A/zh active Pending
- 1998-04-07 EE EEP199900448A patent/EE9900448A/xx unknown
- 1998-04-07 CZ CZ19993551A patent/CZ355199A3/cs unknown
- 1998-04-07 NZ NZ338006A patent/NZ338006A/en unknown
- 1998-04-07 WO PCT/SE1998/000641 patent/WO1998045294A1/en not_active Ceased
- 1998-04-07 US US09/101,165 patent/US6303613B1/en not_active Expired - Fee Related
- 1998-04-07 EP EP98917860A patent/EP0973772A1/en not_active Ceased
- 1998-04-07 SK SK1289-99A patent/SK128999A3/sk unknown
- 1998-04-07 KR KR19997009222A patent/KR20010006143A/ko not_active Withdrawn
- 1998-04-07 HU HU0001865A patent/HUP0001865A2/hu unknown
1999
- 1999-10-05 IS IS5208A patent/IS5208A/is unknown
- 1999-10-08 NO NO994900A patent/NO994900L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
PL336141A1 (en)	2000-06-05
IL132085A0 (en)	2001-03-19
US6303613B1 (en)	2001-10-16
HUP0001865A2 (hu)	2001-01-29
CN1259131A (zh)	2000-07-05
NO994900L (no)	1999-11-19
TR199902495T2 (xx)	2000-07-21
BR9807950A (pt)	2000-03-08
IS5208A (is)	1999-10-05
WO1998045294A1 (en)	1998-10-15
MX9909188A (en)	2001-07-01
CA2285388A1 (en)	1998-10-15
EP0973772A1 (en)	2000-01-26
NZ338006A (en)	2001-04-27
EE9900448A (et)	2000-04-17
SK128999A3 (en)	2000-05-16
ID23861A (id)	2000-05-25
KR20010006143A (ko)	2001-01-26
CZ355199A3 (cs)	2000-03-15
AU7091098A (en)	1998-10-30
SE9701304D0 (sv)	1997-04-09
JP2001519805A (ja)	2001-10-23

Publication	Publication Date	Title
PT860428E (pt)	2005-04-29	Compostos pirimidiona
IS5479A (is)	2000-05-03	Efnasambönd
IS5478A (is)	2000-05-03	Efnasambönd
IS5477A (is)	2000-05-03	Efnasambönd
ID22850A (id)	1999-12-09	Senyawa-senyawa pirazina
EE200000044A (et)	2000-10-16	Uued ühendid
NO994877D0 (no)	1999-10-07	Kalsilytiske forbindelser
EE200000321A (et)	2001-08-15	Uudsed ühendid
ID20323A (id)	1998-11-26	Senyawa-senyawa triazinilaminostilbena
EE9900448A (et)	2000-04-17	Ühendid
EE9900475A (et)	2000-06-15	Ühendid
IS5323A (is)	1999-12-28	Efnasambönd
ID22983A (id)	1999-12-23	Senyawa-senyawa fluorometoksimino
IS5211A (is)	1999-10-12	Efnasambönd
DE69737634D1 (de)	2007-05-31	Insektizide oxadiazinverbindungen
SE9702775D0 (sv)	1997-07-22	Novel compounds
SE9701964D0 (sv)	1997-05-26	Compounds
ID21202A (id)	1999-05-06	Senyawa heterosiklik
SE9701397D0 (sv)	1997-04-15	Compounds
ID18388A (id)	1998-04-02	Senyawa-senyawa heterosiklik
SE9704837D0 (sv)	1997-12-22	New compounds
SE9702696D0 (sv)	1997-07-14	New compounds
SE9702746D0 (sv)	1997-07-18	New compounds
SE9702747D0 (sv)	1997-07-18	New compounds
SE9702535D0 (sv)	1997-07-01	New compounds

Legal Events

Date	Code	Title	Description
2002-10-14	FC2A	Withdrawal, rejection or dismissal of laid open patent application